Use of bevacizumab as an additional strategy in angle closure glaucoma 
– case report

Iwona Helemejko; Joanna Jurowska-Liput

Full text

1/2010 vol. 112

Case report

Use of bevacizumab as an additional strategy in angle closure glaucoma – case report

Iwona Helemejko ¹

,

Joanna Jurowska-Liput ¹

Z Katedry i Kliniki Okulistyki Akademii Medycznej we Wrocławiu

Data publikacji online: 2010/03/21

Article file

12_001_2010_helemejko_zastosowanie.pdf

AMA

Helemejko I, Jurowska-Liput J. Use of bevacizumab as an additional strategy in angle closure glaucoma – case report. Klinika Oczna / Acta Ophthalmologica Polonica. 2010;112(1):61-62.

APA

Helemejko, I., & Jurowska-Liput, J. (2010). Use of bevacizumab as an additional strategy in angle closure glaucoma – case report. Klinika Oczna / Acta Ophthalmologica Polonica, 112(1), 61-62.

Chicago

Helemejko, Iwona, and Joanna Jurowska-Liput. 2010. "Use of bevacizumab as an additional strategy in angle closure glaucoma – case report". Klinika Oczna / Acta Ophthalmologica Polonica 112 (1): 61-62.

Harvard

Helemejko, I., and Jurowska-Liput, J. (2010). Use of bevacizumab as an additional strategy in angle closure glaucoma – case report. Klinika Oczna / Acta Ophthalmologica Polonica, 112(1), pp.61-62.

MLA

Helemejko, Iwona et al. "Use of bevacizumab as an additional strategy in angle closure glaucoma – case report." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 112, no. 1, 2010, pp. 61-62.

Vancouver

Helemejko I, Jurowska-Liput J. Use of bevacizumab as an additional strategy in angle closure glaucoma – case report. Klinika Oczna / Acta Ophthalmologica Polonica. 2010;112(1):61-62.

SUBMIT YOUR PAPER

Share

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications